United Therapeutics
UTHR
UTHR
507 hedge funds and large institutions have $10B invested in United Therapeutics in 2023 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 173 increasing their positions, 180 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 180
1.39% less ownership
Funds ownership: 95.92% → 94.53% (-1.4%)
29% less call options, than puts
Call options by funds: $25.6M | Put options by funds: $36M
Holders
507
Holding in Top 10
18
Calls
$25.6M
Puts
$36M
Top Buyers
| 1 | +$34.1M | |
| 2 | +$26.2M | |
| 3 | +$25.2M | |
| 4 |
Amundi
Paris,
France
|
+$20.5M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$15.6M |
Top Sellers
| 1 | -$128M | |
| 2 | -$90.1M | |
| 3 | -$42.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34.2M |
| 5 |
LAM
L2 Asset Management
Wayland,
Massachusetts
|
-$28.2M |